You all know how much I love the CDGEMM Study (Celiac Disease Genomic, Environmental, Microbiome & Metabolomic Study) from Massachusetts General Hospital in Boston.
The CDGEMM Study follows infants and young children who have a first-degree relative (a parent or sibling) with celiac disease, from birth up to age 10. Researchers are looking at how genetics, environment, gut microbiome changes, and how food is digested might all influence who eventually develops celiac disease.
If you want to dig into the details, you can read more about the study design and goals here:
- CDGEMM study design paper (Leonard et al.)
- Multi-omics analysis of infants at risk for celiac disease (Leonard et al., Microbiome)
- Cohort profile of the CDGEMM Study (Leonard et al., PLOS One)
- How microbes go astray in infants at risk for celiac disease (Celiac Disease Foundation)
What CDGEMM Is Showing Us So Far
1. Genetics influence the gut microbiome early
One of the key findings so far is that genetics help shape the gut microbiome in early life. For example, infants who carry two copies of the HLA-DQ2 gene (a high-risk gene for celiac disease) show different patterns in how their gut microbes function and metabolize nutrients.
This may make them more vulnerable to gut-related problems. However:
- This effect has been clearly seen before solid foods are introduced.
- Researchers have not yet shown a direct, guaranteed link between these microbiome changes and actually developing celiac disease.
2. Celiac disease doesn’t always “slowly build”
Recent CDGEMM data suggests that, in many children, celiac disease does not develop as a slow, gradual climb in antibodies over many years. Instead, some children go from having no detectable celiac antibodies to having significantly elevated levels within about six months.
For kids who are genetically at risk, this raises an important point: if changes can happen this quickly, then long gaps between tests may miss the window where damage is starting.
What This Means for Screening
Right now, many guidelines suggest screening high-risk patients (those with a family history or genetic risk) about every two years, or sooner if symptoms appear.
Based on what we’re learning from CDGEMM, it is very reasonable to talk with your child’s doctor about:
- More regular celiac antibody testing for children with a first-degree relative with celiac disease.
- Considering annual screening as part of their routine care, especially if they carry celiac-associated genes like HLA-DQ2 or HLA-DQ8.
Honestly, celiac screening probably deserves a spot in the annual physical for:
- Children with a parent or sibling who has celiac disease
- Adults with a first-degree relative with celiac disease
- Anyone with ongoing, unexplained symptoms that might fit celiac disease
But I’m not the one writing the guidelines—I’m just paying attention.
What I am saying is this: if your child (or you) is at higher risk, CDGEMM is giving us more evidence that regular, proactive screening isn’t overreacting—it’s smart.
Links for additional information:
Why I Post About Celiac Disease